Myriad Genetics, Inc. (NASDAQ:MYGN) Q4 2023 Earnings Call Transcript
Myriad Genetics, Inc. beats earnings expectations. Reported EPS is $0.04, expectations were $0.02. Myriad Genetics, Inc.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Glenview Capital Larry Robbins | 5,283,982 | $101,135,415 | +40% | 2.16% |
2. | Millennium Management Israel Englander | 3,461,337 | $66,249,990 | -1% | 0.02% |
3. | D E Shaw D. E. Shaw | 1,801,306 | $34,476,997 | -18% | 0.03% |
4. | Citadel Investment Group Ken Griffin | 1,164,082 | $22,280,529 | +73% | 0% |
5. | Fisher Asset Management Ken Fisher | 157,969 | $3,023,525 | +11% | 0% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$16.62 | 15,000 | Director | 66,790 | 2020-11-11 | Filing | |
$25.60 | 5,860 | Director | 54,150 | 2019-12-13 | Filing | |
$23.46 | 1,750 | Director | 2,050 | 2019-11-07 | Filing | |
$23.46 | 5,250 | Director | 64,353 | 2019-11-07 | Filing | |
$18.57 | 400 | Director | 42,524 | 2017-02-23 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$19.09 | 30,000 | Officer | 291,812 | 2023-12-01 | Filing | |
$15.69 | 30,000 | Officer | 321,812 | 2023-11-01 | Filing | |
$23.01 | 8,638 | Director | 40,493 | 2023-06-02 | Filing | |
$23.48 | 6,433 | Officer | 240,506 | 2023-03-27 | Filing | |
$22.55 | 15,000 | Officer | 337,885 | 2023-03-02 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 14,658,349 | $280,560,800 | 0% | |
2. | 9,954,233 | $190,524,020 | 0% | |
3. | 7,219,706 | $138,185,172 | 0.02% | |
4. | 4,700,631 | $89,970,077 | 0% | |
5. | 3,913,913 | $74,912,295 | 0.37% |